ZBTB7A and glioblastoma: Moreover, overexpression of ZBTB7A significantly inhibited the aerobic glycolytic and proliferative capacity of IDH1WT GBM cells, whereas the knockdown of ZBTB7A significantly enhanced the aerobic glycolytic and proliferative capacity of IDH1WT GBM cells.